Insights
Search results
Article | November 05, 2014
The Patent Use Code Conundrum — or Why FDA Can't Read (Patents)
Read more
Article | October 07, 2014
The Efficiency of Bringing Drugs to Market Versus the Fairness of Making Drugs Accessible
Read more
Article | March 07, 2014
Drug Labeling Games: Skinny Labels Getting an FDA Assist
Read more
Article | November 22, 2013
Hatch-Waxman Developments: Artificial Infringement by Artificial Drugs
Read more
Blog | November 05, 2013
Mobile Medical Apps: FDA Issues Final Guidance
Read more
Blog | October 16, 2013
New FDA Rule on "unique device identifier" (UDI) Marking Requirements
Read more
Blog | August 19, 2013
FCC Enforcement Update: August 2013
Read more
Blog | February 12, 2013
New FCC Licensing Rules for Independent Test Labs
Read more
Article | January 24, 2013
Personalized Medicine-Slowing Down for "Free Riders"
Read more
Article | October 09, 2012
Interchangeable Biosimilars - Time to Reform the Orange Book
Read more
Article | March 13, 2012
Biosimilars vs. Generics - Major Differences in the Regulatory Model
Read more
Article | December 02, 2011